About Antimicrobial Susceptibility Testing and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Expert Update

This event is co-organised by CRE REDUCE, UQ and CHU Nîmes.


Date: 3 - 5.30pm, Tuesday 27 October 2020
Antimicrobial susceptibility testing of microbial pathogens is a core and essential component of a clinical microbiological laboratory's guidance for optimal therapy. Clinicians at the bedside are reliant on knowledge of whether a microbial isolate is S for success! However, EUCAST has changed the definitions of susceptibility testing categories S, I and R. The purpose of this meeting is to detail these changes and address implications for implementation and reporting.

Speakers include Prof John Turnidge - EUCAST Scientific Secretary and ACSQHC Senior Clinical Advisor (Adelaide), Prof Gunnar Kahlmeter - MD, EUCAST Steering committee and Head of the EUCAST Development Laboratory (Sweden), and Prof Jean-Philippe Lavigne from Centre Hospitalier Régional Universitaire de Nîmes (France).

Time Topic Speaker/Facilitator

Susceptibility testing - A European perspective 


Prof Jean-Philippe Lavigne

Moderator: Prof Jason Roberts


EUCAST updates - putting I first


Prof Gunnar Kahlmeter and Prof John Turnidge

Moderator: Dr Andrew Henderson 


Q&A session

Moderators: Dr Andrew Henderson and Dr Patrick Harris
1730 Close


Thank you to our sponsors for the support provided to these events to help with the sharing of current research and knowledge.



Webinar delivery. Details provided upon registration.